Skip to content

Psychedelic-assisted therapy: all studies

Page 289 of 294: studies 2,881 to 2,890 of 2,936, newest first. Back to the psychedelic-assisted therapy overview

Research

A Clinical Plan for MDMA (Ecstasy) in the Treatment of Posttraumatic Stress Disorder (PTSD): Partnering with the FDA

Journal of Psychoactive Drugs June 1, 2002 Rick Doblin 98 citations

The FDA and the Spanish Ministry of Health have concluded that the risk/benefit ratio is favorable under certain circumstances for clinical studies investigating MDMA-assisted psychotherapy. Both agencies have approved pilot studies in chronic posttraumatic stress disorder (PTSD) patients who have failed to obtain relief from at least one course of conventional treatment. These studies, the...

DOI: 10.1080/02791072.2002.10399952 (opens in new tab) MDMA Ecstasy Posttraumatic stress Multidisciplinary approach +2

Serotonin model of schizophrenia: emerging role of glutamate mechanisms.

Brain research. Brain research reviews March 2000 George K. Aghajanian, Gerard J. Marek

The serotonin (5-HT) hypothesis of schizophrenia arose from early studies on interactions between the hallucinogenic drug LSD (D-lysergic acid diethylamide) and 5-HT in peripheral systems. More recent studies have shown that the two major classes of psychedelic hallucinogens, the indoleamines (e.g., LSD) and phenethylamines (e.g. , mescaline), produce their central effects through a common...

Towards a neural network based therapy for hallucinatory disorders.

Neural Networks 2000 J R Peláez

Pattern completion in a neural network model of the thalamus and a biologically plausible model of synaptic plasticity are the key concepts used in this paper for analyzing some cognitive disorders that involve hallucinations of several kinds: visual hallucinations in the Charles Bonnet syndrome and psychedelic drugs consumption, somatic hallucination in phantom limbs, cognitive hallucinations...

Hallucinogenic Drugs and Plants in Psychotherapy and Shamanism

Journal of Psychoactive Drugs December 1, 1998 Ralph Metzner 140 citations

Western psychotherapy and indigenous shamanic healing systems have both used psychoactive drugs or plants for healing and obtaining knowledge (called "diagnosis" or "divination" respectively). While there are superficial similarities between psychedelic-assisted psychotherapy and shamanic healing with hallucinogenic plants, there are profound differences in the underlying worldview and...

Hallucinogens, serotonin and obsessive-compulsive disorder.

Journal of Psychoactive Drugs 1998 P L Delgado, F A Moreno

The serotonin (5-HT) neurotransmitter system has been implicated in the pathophysiology of several neuropsychiatric disorders, especially obsessive-compulsive disorder (OCD). Blockade of 5-HT reuptake appears to be an important initial neurobiological event in the therapeutic mechanism of action of antiobsessional drugs. However, for reasons that continue to be poorly understood, clinical...

Set, Setting, and Matrix

Journal of Psychoactive Drugs June 1, 1997 Betty Grover Eisner 129 citations

The future use of psychedelics as an aid to therapeutic change is bound to come. The best source of information on how to use these extraordinary drugs is clearly a detailed description of the successes (and failures) of those researchers who have used these compounds to bring curative, creative and growth-potentiating experiences to their patients. A study of their work is recommended in order...

Problemática de las subastas de arte en España

Dialnet (Universidad de la Rioja) 1996 Pablo López de Osaba

Psilocybin is investigated as a fast-acting antidepressant used in conjunction with psychotherapy. Intact cognitive functions, including memory, are one of the basic conditions of effective psychedelic-assisted therapy. While cognitive and memory processing is attenuated on various domains during psilocybin intoxication, the effect of psilocybin on the consolidation of memories learned outside...

Psychedelic and Entactogenic Drugs in the Treatment of Depression

Journal of Psychoactive Drugs 1994 Thomas J. Riedlinger, June E. Riedlinger 39 citations

CNS deficiency of 5-hydroxytryptamine (serotonin) has been implicated as a biochemical basis in some forms of depression. Existing drug modalities for treating depression include some with serotonergic effects. Studies suggest that psychedelic drugs are also serotonergic. This may indicate a role for psychedelics in the treatment of depression. Such treatment has already been attempted using...

Existential Transactions at Harvard

Journal of Humanistic Psychology July 1, 1993 Thomas J. Riedlinger 6 citations

Before gaining notoriety as a promoter of the psychedelic drug experience, Timothy Leary established impressive credentials in the field of interpersonal psychology and was developing a humanistic form of psychotherapy he called "existential-transactional." This article plots the evolution of his work in these areas, from publication of his classic Interpersonal Diagnosis of Personality (1957),...